
NATURE . COM {
}
Title:
Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment | Nature Communications
Description:
Specific targeting and cellular internalization are key properties for carriers of antitumor therapeutic agents. Here, we develop a drug carrier through the attachment of substrate of endoprotease legumain, alanine–alanine–asparagine (AAN), to cell-penetrating peptides (TAT, trans-activating factor). The addition of the AAN moiety to the fourth lysine in the TAT creates a branched peptide moiety, which leads to a decrease in the transmembrane transport capacity of TAT by 72.65%. Legumain efficiently catalyses the release of TAT-liposome from the AAN-TAT-liposome and thereby recovers the penetrating capacity of TAT. Doxorubicin carried by the AAN-TAT-liposome led to an increase in the tumoricidal effect of doxorubicin and a reduction in its systemic adverse effects in comparison with doxorubicin carried by a control delivery system. Thus, the specific targeting and high efficiency of this delivery platform offers a novel approach to limit the toxicity of anticancer agents as well as increasing their efficacy in cancer therapy. Legumain is a protease found expressed in tumour cells and may be useful in the specific targeting of chemotherapeutics to tumour cells. Here, the authors design nanoparticles that are loaded with doxorubicin and contain a legumain cleavage site; once the nanoparticles enter tumour cells legumain activity results in the release of doxorubicin.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌆 Monumental Traffic: 20M - 50M visitors per month
Based on our best estimate, this website will receive around 42,799,894 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$539,300 per month
Estimations show Nature.com's display ad online revenue falls between $359,561 and $988,793 per month.
Keywords {🔍}
legumain, cells, nanoparticles, tumour, cancer, article, doxorubicin, pubmed, aantatlipo, google, scholar, cas, fig, drug, breast, analysis, cell, tat, results, shown, expression, loaded, data, delivery, mouse, mice, substrate, macrophages, lysates, nature, targeting, aan, tissue, incubated, treatment, peptide, supplementary, activity, liposomal, china, usa, active, aantatlipodox, site, control, human, antibody, group, represent, model,
Topics {✒️}
nature portfolio 2-dioleoyl-sn-glycero-3-phospho-ethanolamine-n-[methoxy author information authors carbobenzyloxy–alanine–alanine–asparagine–ethylenediamine–etoposide permissions reprints privacy policy plv-ef1α-legumain-ires-bsd plasmid plv-ef1α-luciferase-ires-bsd middle line represents legumain-specific substrate ala–ala–asn jandel scientific software fitc-labelled aan-tat-lipo-dox luciferase-expressing mda-mb-231 cells fitc-labelled aan-tat-lipo nanoparticles aan-tat-lipo-dox administration group aan-tat-lipo-dox treatment group advertising nature aan-tat-lipo carrying biomacromolecules aan-tat-nanoparticles sheds light aan-tat-lipo-dox group scripps research institute aan-tat-lipo nanoparticles produced aan-tat-lipo nanoparticle structure additional information doxorubicin-loaded aan-tat-lipo nanoparticles social media oriented central-tumor delivery aan-tat-lipo-egfp group ala–ala–asn–amc41 dir-labelled aan-tat-lipo ala–ala–asn–amc mda-mb-231 mouse model 2-dioleoyl-sn-glycero-3-phosphoethanolamine 2-dioleoyl-sn-glycero-3-phosphocholine aan-tat-lipo carrier system aan-tat-lipo enhances internalization commercial substrate z-aan-amc tat-lipo-dox experimental groups aan-tat-lipo increases accumulation cleaves aan-tat-lipo luciferase-expressing a549 cells tat-lipo-dox treatment groups luciferase-expressing 4t1 cells legumain substrate z-aan-amc japan full access establishing stable legumain-expressing aan-tan-lipo nanoparticles luciferase-expressing cell lines
Schema {🗺️}
WebPage:
mainEntity:
headline:Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment
description:Specific targeting and cellular internalization are key properties for carriers of antitumor therapeutic agents. Here, we develop a drug carrier through the attachment of substrate of endoprotease legumain, alanineâalanineâasparagine (AAN), to cell-penetrating peptides (TAT, trans-activating factor). The addition of the AAN moiety to the fourth lysine in the TAT creates a branched peptide moiety, which leads to a decrease in the transmembrane transport capacity of TAT by 72.65%. Legumain efficiently catalyses the release of TAT-liposome from the AAN-TAT-liposome and thereby recovers the penetrating capacity of TAT. Doxorubicin carried by the AAN-TAT-liposome led to an increase in the tumoricidal effect of doxorubicin and a reduction in its systemic adverse effects in comparison with doxorubicin carried by a control delivery system. Thus, the specific targeting and high efficiency of this delivery platform offers a novel approach to limit the toxicity of anticancer agents as well as increasing their efficacy in cancer therapy. Legumain is a protease found expressed in tumour cells and may be useful in the specific targeting of chemotherapeutics to tumour cells. Here, the authors design nanoparticles that are loaded with doxorubicin and contain a legumain cleavage site; once the nanoparticles enter tumour cells legumain activity results in the release of doxorubicin.
datePublished:2014-06-27T00:00:00Z
dateModified:2014-06-27T00:00:00Z
pageStart:1
pageEnd:11
sameAs:https://doi.org/10.1038/ncomms5280
keywords:
Drug delivery
Targeted therapies
Science
Humanities and Social Sciences
multidisciplinary
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Figa_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig6_HTML.jpg
isPartOf:
name:Nature Communications
issn:
2041-1723
volumeNumber:5
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Ze Liu
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Min Xiong
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Junbo Gong
affiliation:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road
address:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yan Zhang
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Nan Bai
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yunping Luo
affiliation:
name:Beijing Union Medical School, 5 Dong Dan San Tiao
address:
name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
type:PostalAddress
type:Organization
type:Person
name:Luyuan Li
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yuquan Wei
affiliation:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
address:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
type:PostalAddress
type:Organization
type:Person
name:Yanhua Liu
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Xiaoyue Tan
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Rong Xiang
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment
description:Specific targeting and cellular internalization are key properties for carriers of antitumor therapeutic agents. Here, we develop a drug carrier through the attachment of substrate of endoprotease legumain, alanineâalanineâasparagine (AAN), to cell-penetrating peptides (TAT, trans-activating factor). The addition of the AAN moiety to the fourth lysine in the TAT creates a branched peptide moiety, which leads to a decrease in the transmembrane transport capacity of TAT by 72.65%. Legumain efficiently catalyses the release of TAT-liposome from the AAN-TAT-liposome and thereby recovers the penetrating capacity of TAT. Doxorubicin carried by the AAN-TAT-liposome led to an increase in the tumoricidal effect of doxorubicin and a reduction in its systemic adverse effects in comparison with doxorubicin carried by a control delivery system. Thus, the specific targeting and high efficiency of this delivery platform offers a novel approach to limit the toxicity of anticancer agents as well as increasing their efficacy in cancer therapy. Legumain is a protease found expressed in tumour cells and may be useful in the specific targeting of chemotherapeutics to tumour cells. Here, the authors design nanoparticles that are loaded with doxorubicin and contain a legumain cleavage site; once the nanoparticles enter tumour cells legumain activity results in the release of doxorubicin.
datePublished:2014-06-27T00:00:00Z
dateModified:2014-06-27T00:00:00Z
pageStart:1
pageEnd:11
sameAs:https://doi.org/10.1038/ncomms5280
keywords:
Drug delivery
Targeted therapies
Science
Humanities and Social Sciences
multidisciplinary
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Figa_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig6_HTML.jpg
isPartOf:
name:Nature Communications
issn:
2041-1723
volumeNumber:5
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Ze Liu
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Min Xiong
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Junbo Gong
affiliation:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road
address:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yan Zhang
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Nan Bai
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yunping Luo
affiliation:
name:Beijing Union Medical School, 5 Dong Dan San Tiao
address:
name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
type:PostalAddress
type:Organization
type:Person
name:Luyuan Li
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yuquan Wei
affiliation:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
address:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
type:PostalAddress
type:Organization
type:Person
name:Yanhua Liu
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Xiaoyue Tan
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Rong Xiang
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Nature Communications
issn:
2041-1723
volumeNumber:5
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road
address:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:Beijing Union Medical School, 5 Dong Dan San Tiao
address:
name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
address:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Ze Liu
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Min Xiong
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Junbo Gong
affiliation:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road
address:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Yan Zhang
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Nan Bai
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Yunping Luo
affiliation:
name:Beijing Union Medical School, 5 Dong Dan San Tiao
address:
name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
type:PostalAddress
type:Organization
name:Luyuan Li
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Yuquan Wei
affiliation:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
address:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
type:PostalAddress
type:Organization
name:Yanhua Liu
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Xiaoyue Tan
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
name:Rong Xiang
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
Social Networks {👍}(2)
External Links {🔗}(168)
- What are the total earnings of https://doi.org/10.1021%2Fnn4047925?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24144228?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Layer-by-layer%20nanoparticles%20for%20systemic%20codelivery%20of%20an%20anticancer%20drug%20and%20sirna%20for%20potential%20triple-negative%20breast%20cancer%20treatment&journal=ACS%20Nano&doi=10.1021%2Fnn4047925&volume=7&pages=9571-9584&publication_year=2013&author=Deng%2CZJ
- Revenue of https://doi.org/10.1038%2Fnrc1893
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16862189
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Drug%20penetration%20in%20solid%20tumours&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2Fnrc1893&volume=6&pages=583-592&publication_year=2006&author=Minchinton%2CAI&author=Tannock%2CIF
- How much profit is https://doi.org/10.1002%2Fanie.200301694 making per month?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Supramolecular%20drug-delivery%20systems%20based%20on%20polymeric%20core-shell%20architectures&journal=Angew.%20Chem.%20Int.%20Ed.&doi=10.1002%2Fanie.200301694&volume=43&pages=278-282&publication_year=2004&author=Haag%2CR
- Discover the revenue of https://doi.org/10.2217%2Fnnm.13.11
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Polymer%20nanocompartments%20in%20broad-spectrum%20medical%20applications&journal=Nanomedicine%20%28Lond%29&doi=10.2217%2Fnnm.13.11&volume=8&pages=425-447&publication_year=2013&author=Najer%2CA&author=Wu%2CD&author=Vasquez%2CD&author=Palivan%2CCG&author=Meier%2CW bring in?
- How much does https://doi.org/10.1016%2Fj.jconrel.2013.09.015 earn?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24075926
- Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891846 earns monthly
- http://scholar.google.com/scholar_lookup?&title=Progress%20in%20microRNA%20delivery&journal=J.%20Control.%20Release&doi=10.1016%2Fj.jconrel.2013.09.015&volume=172&pages=962-974&publication_year=2013&author=Zhang%2CY&author=Wang%2CZ&author=Gemeinhart%2CRA's total income per month
- Get to know what's the income of https://doi.org/10.1155%2F2013%2F705265
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23533772
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606784?
- How much does http://scholar.google.com/scholar_lookup?&title=Recent%20trends%20in%20multifunctional%20liposomal%20nanocarriers%20for%20enhanced%20tumor%20targeting&journal=J.%20Drug%20Deliv.&doi=10.1155%2F2013%2F705265&volume=2013&publication_year=2013&author=Perche%2CF&author=Torchilin%2CVP earn?
- https://doi.org/10.1016%2Fj.molmed.2012.04.012's revenue stream
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22682515
- How much does http://scholar.google.com/scholar_lookup?&title=Cell-penetrating%20peptides%3A%20breaking%20through%20to%20the%20other%20side&journal=Trends%20Mol.%20Med.&doi=10.1016%2Fj.molmed.2012.04.012&volume=18&pages=385-393&publication_year=2012&author=Koren%2CE&author=Torchilin%2CVP net monthly?
- How much income does https://doi.org/10.1016%2Fj.ijpharm.2011.09.008 have?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21945185 pull in monthly?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Liposome%20formulated%20with%20TAT-modified%20cholesterol%20for%20improving%20brain%20delivery%20and%20therapeutic%20efficacy%20on%20brain%20glioma%20in%20animals&journal=Int.%20J.%20Pharm.&doi=10.1016%2Fj.ijpharm.2011.09.008&volume=420&pages=304-312&publication_year=2011&author=Qin%2CY?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18440319's earnings
- How much money does http://scholar.google.com/scholar_lookup?&title=Cell-penetrating%20and%20cell-targeting%20peptides%20in%20drug%20delivery&journal=Biochim.%20Biophys.%20Acta.&volume=1786&pages=126-138&publication_year=2008&author=Vives%2CE&author=Schmidt%2CJ&author=Pelegrin%2CA make?
- https://doi.org/10.1016%2Fj.jconrel.2012.06.019's total income per month
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22728515?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Size-controlled%20dual-ligand%20modified%20liposomes%20that%20target%20the%20tumor%20vasculature%20show%20promise%20for%20use%20in%20drug-resistant%20cancer%20therapy&journal=J.%20Control.%20Release&doi=10.1016%2Fj.jconrel.2012.06.019&volume=162&pages=225-232&publication_year=2012&author=Takara%2CK generate?
- What's https://doi.org/10.1016%2Fj.ijpharm.2011.03.010's gross income?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21414394?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=A%20new%20peptide%20motif%20present%20in%20the%20protective%20antigen%20of%20anthrax%20toxin%20exerts%20its%20efficiency%20on%20the%20cellular%20uptake%20of%20liposomes%20and%20applications%20for%20a%20dual-ligand%20system&journal=Int.%20J.%20Pharm.&doi=10.1016%2Fj.ijpharm.2011.03.010&volume=412&pages=106-114&publication_year=2011&author=Kibria%2CG&author=Hatakeyama%2CH&author=Harashima%2CH?
- What is the earnings of https://doi.org/10.1016%2Fj.biomaterials.2010.10.037?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21074847?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Integrin-targeted%20nanocomplexes%20for%20tumour%20specific%20delivery%20and%20therapy%20by%20systemic%20administration&journal=Biomaterials&doi=10.1016%2Fj.biomaterials.2010.10.037&volume=32&pages=1370-1376&publication_year=2011&author=Tagalakis%2CAD?
- Check the income stats for https://doi.org/10.1016%2Fj.cell.2011.02.013
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21376230 income
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Hallmarks%20of%20cancer%3A%20the%20next%20generation&journal=Cell&doi=10.1016%2Fj.cell.2011.02.013&volume=144&pages=646-674&publication_year=2011&author=Hanahan%2CD&author=Weinberg%2CRA?
- How much does https://doi.org/10.1615%2FCritRevOncog.v18.i1-2.70 pull in?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23237555 make?
- Income figures for http://scholar.google.com/scholar_lookup?&title=The%20tumor%20microenvironment%3A%20a%20target%20for%20combination%20therapy%20of%20breast%20cancer&journal=Crit.%20Rev.%20Oncog.&doi=10.1615%2FCritRevOncog.v18.i1-2.70&volume=18&pages=115-133&publication_year=2013&author=Reisfeld%2CRA
- How much revenue does https://doi.org/10.1038%2Fnm.3337 bring in?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24056773 bring in?
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840724 income
- How much does http://scholar.google.com/scholar_lookup?&title=CSF-1R%20inhibition%20alters%20macrophage%20polarization%20and%20blocks%20glioma%20progression&journal=Nat.%20Med.&doi=10.1038%2Fnm.3337&volume=19&pages=1264-1272&publication_year=2013&author=Pyonteck%2CSM make?
- What's the income of https://doi.org/10.1111%2Fcas.12202?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23691974 earn?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766435?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Selective%20ablation%20of%20tumor-associated%20macrophages%20suppresses%20metastasis%20and%20angiogenesis&journal=Cancer%20Sci.&doi=10.1111%2Fcas.12202&volume=104&pages=1217-1225&publication_year=2013&author=Lin%2CY?
- How much does https://doi.org/10.1172%2FJCI27648 net monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16862213 pull in?
- What's the profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513049?
- What's http://scholar.google.com/scholar_lookup?&title=Targeting%20tumor-associated%20macrophages%20as%20a%20novel%20strategy%20against%20breast%20cancer&journal=J.%20Clin.%20Invest.&doi=10.1172%2FJCI27648&volume=116&pages=2132-2141&publication_year=2006&author=Luo%2CY's gross income?
- How much money does https://link.springer.com/doi/10.1007/s00262-007-0389-x generate?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17786443
- Profit of http://scholar.google.com/scholar_lookup?&title=A%20legumain-based%20minigene%20vaccine%20targets%20the%20tumor%20stroma%20and%20suppresses%20breast%20cancer%20growth%20and%20angiogenesis&journal=Cancer%20Immunol.%20Immunother.&doi=10.1007%2Fs00262-007-0389-x&volume=57&pages=507-515&publication_year=2008&author=Lewen%2CS
- What are the total earnings of https://doi.org/10.1111%2Fj.1600-065X.2008.00613.x?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18363997 earn?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Oral%20DNA%20vaccines%20target%20the%20tumor%20vasculature%20and%20microenvironment%20and%20suppress%20tumor%20growth%20and%20metastasis&journal=Immunol.%20Rev.&doi=10.1111%2Fj.1600-065X.2008.00613.x&volume=222&pages=117-128&publication_year=2008&author=Xiang%2CR&author=Luo%2CY&author=Niethammer%2CAG&author=Reisfeld%2CRA?
- Discover the revenue of https://doi.org/10.1073%2Fpnas.1300686110
- How much profit does http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2013PNAS..11010940D generate?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23776206 generate?
- Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703970
- How much does http://scholar.google.com/scholar_lookup?&title=Mechanistic%20and%20structural%20studies%20on%20legumain%20explain%20its%20zymogenicity%2C%20distinct%20activation%20pathways%2C%20and%20regulation&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.1300686110&volume=110&pages=10940-10945&publication_year=2013&author=Dall%2CE&author=Brandstetter%2CH bring in each month?
- How much does https://doi.org/10.1096%2Ffj.10-172312 earn?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21292981 generate?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Asparagine%20endopeptidase%20is%20required%20for%20normal%20kidney%20physiology%20and%20homeostasis&journal=FASEB%20J.&doi=10.1096%2Ffj.10-172312&volume=25&pages=1606-1617&publication_year=2011&author=Miller%2CG&author=Matthews%2CSP&author=Reinheckel%2CT&author=Fleming%2CS&author=Watts%2CC?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12782603?
- http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20legumain%20in%20tumors%20is%20significant%20for%20invasion%2Fmetastasis%20and%20a%20candidate%20enzymatic%20target%20for%20prodrug%20therapy&journal=Cancer%20Res.&volume=63&pages=2957-2964&publication_year=2003&author=Liu%2CC&author=Sun%2CC&author=Huang%2CH&author=Janda%2CK&author=Edgington%2CT's revenue stream
- Get to know what's the income of https://doi.org/10.1016%2Fj.biomaterials.2013.09.100
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24120038
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Peptide-based%20MRI%20contrast%20agent%20and%20near-infrared%20fluorescent%20probe%20for%20intratumoral%20legumain%20detection&journal=Biomaterials&doi=10.1016%2Fj.biomaterials.2013.09.100&volume=35&pages=304-315&publication_year=2013&author=Chen%2CYJ
- What's the financial intake of https://link.springer.com/doi/10.1007/s12032-013-0621-9?
- What's the financial gain of http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2013tdsc.book.....L?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23740003 rake in every month?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Effects%20of%20legumain%20as%20a%20potential%20prognostic%20factor%20on%20gastric%20cancers&journal=Med.%20Oncol.&doi=10.1007%2Fs12032-013-0621-9&volume=30&publication_year=2013&author=Li%2CN
- Financial intake of https://doi.org/10.1016%2Fj.nano.2011.03.001
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21419870?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Synthetic%20enzyme%20inhibitor%3A%20a%20novel%20targeting%20ligand%20for%20nanotherapeutic%20drug%20delivery%20inhibiting%20tumor%20growth%20without%20systemic%20toxicity&journal=Nanomedicine&doi=10.1016%2Fj.nano.2011.03.001&volume=7&pages=665-673&publication_year=2011&author=Liao%2CD have monthly?
- How much revenue does https://doi.org/10.1021%2Fja307083b generate?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23215039?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Functional%20imaging%20of%20legumain%20in%20cancer%20using%20a%20new%20quenched%20activity-based%20probe&journal=J.%20Am.%20Chem.%20Soc.&doi=10.1021%2Fja307083b&volume=135&pages=174-182&publication_year=2013&author=Edgington%2CLE
- How much profit does https://doi.org/10.1021%2Fmp200434n generate?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22044266?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Targeting%20cell%20surface%20alpha%28v%29beta%283%29%20integrin%20increases%20therapeutic%20efficacies%20of%20a%20legumain%20protease-activated%20auristatin%20prodrug&journal=Mol.%20Pharm.&doi=10.1021%2Fmp200434n&volume=9&pages=168-175&publication_year=2012&author=Liu%2CY&author=Bajjuri%2CKM&author=Liu%2CC&author=Sinha%2CSC?
- https://doi.org/10.1002%2Fcmdc.201000478's revenue stream
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21154805's earnings
- What's the financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549592?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20legumain%20protease-activated%20auristatin%20prodrugs%20suppress%20tumor%20growth%20and%20metastasis%20without%20toxicity&journal=ChemMedChem&doi=10.1002%2Fcmdc.201000478&volume=6&pages=54-59&publication_year=2011&author=Bajjuri%2CKM&author=Liu%2CY&author=Liu%2CC&author=Sinha%2CSC bring in each month?
- How much revenue does https://doi.org/10.1158%2F0008-5472.CAN-05-2591 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16424032 gross monthly?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Targeting%20cell-impermeable%20prodrug%20activation%20to%20tumor%20microenvironment%20eradicates%20multiple%20drug-resistant%20neoplasms&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-05-2591&volume=66&pages=970-980&publication_year=2006&author=Wu%2CW?
- What are the earnings of https://doi.org/10.1021%2Fbc800448u?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19196156 earning monthly?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=A%20novel%20antitumor%20prodrug%20platform%20designed%20to%20be%20cleaved%20by%20the%20endoprotease%20legumain&journal=Bioconjug.%20Chem.&doi=10.1021%2Fbc800448u&volume=20&pages=500-510&publication_year=2009&author=Stern%2CL
- How much does https://doi.org/10.2217%2Fnnm.13.118 pull in monthly?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Current%20trends%20in%20the%20use%20of%20liposomes%20for%20tumor%20targeting&journal=Nanomedicine%20%28Lond%29&doi=10.2217%2Fnnm.13.118&volume=8&pages=1323-1342&publication_year=2013&author=Deshpande%2CPP&author=Biswas%2CS&author=Torchilin%2CVP
- How much does https://link.springer.com/doi/10.1007/978-1-61779-151-2_23 pull in monthly?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21674343
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Design%20and%20synthesis%20of%20novel%20functional%20lipid-based%20bioconjugates%20for%20drug%20delivery%20and%20other%20applications&journal=Methods%20Mol.%20Biol.&doi=10.1007%2F978-1-61779-151-2_23&volume=751&pages=357-378&publication_year=2011&author=Sawant%2CRR&author=Torchilin%2CVP?
- Earnings of https://doi.org/10.1002%2Fbip.20989
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18381624 generate?
- Get to know http://scholar.google.com/scholar_lookup?&title=Cell%20penetrating%20peptide-modified%20pharmaceutical%20nanocarriers%20for%20intracellular%20drug%20and%20gene%20delivery&journal=Biopolymers&doi=10.1002%2Fbip.20989&volume=90&pages=604-610&publication_year=2008&author=Torchilin%2CVP's earnings
- How much income does https://doi.org/10.1016%2Fj.jconrel.2004.10.018 have?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15653149's total income per month
- How much does http://scholar.google.com/scholar_lookup?&title=Cationic%20TAT%20peptide%20transduction%20domain%20enters%20cells%20by%20macropinocytosis&journal=J.%20Control.%20Release&doi=10.1016%2Fj.jconrel.2004.10.018&volume=102&pages=247-253&publication_year=2005&author=Kaplan%2CIM&author=Wadia%2CJS&author=Dowdy%2CSF gross monthly?
- How much income does http://scholar.google.com/scholar_lookup?&title=SOX2%20regulates%20apoptosis%20through%20MAP4K4-Survivin%20signaling%20pathway%20in%20human%20lung%20cancer%20cells&journal=Carcinogenesis&volume=14&publication_year=2013&author=Chen%2CS have?
- Learn about the earnings of https://doi.org/10.1371%2Fjournal.pone.0060190
- What's http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2013PLoSO...860190L's gross income?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23577091?
- Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618226 earns monthly
- Earnings of http://scholar.google.com/scholar_lookup?&title=Alginic%20acid-coated%20chitosan%20nanoparticles%20loaded%20with%20legumain%20DNA%20vaccine%3A%20effect%20against%20breast%20cancer%20in%20mice&journal=PLoS%20ONE&doi=10.1371%2Fjournal.pone.0060190&volume=8&publication_year=2013&author=Liu%2CZ
- How much revenue does https://doi.org/10.1515%2FBC.2002.133 generate?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12437107 bring in?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20mammalian%20legumain%20by%20Michael%20acceptors%20and%20AzaAsn-halomethylketones&journal=Biol.%20Chem.&doi=10.1515%2FBC.2002.133&volume=383&pages=1205-1214&publication_year=2002&author=Niestroj%2CAJ have monthly?
- How much income is https://doi.org/10.1021%2Fjm049938j earning monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15055989's total income per month
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Aza-peptide%20Michael%20acceptors%3A%20a%20new%20class%20of%20inhibitors%20specific%20for%20caspases%20and%20other%20clan%20CD%20cysteine%20proteases&journal=J.%20Med.%20Chem.&doi=10.1021%2Fjm049938j&volume=47&pages=1889-1892&publication_year=2004&author=Ekici%2COD is on a monthly basis
- Income figures for https://doi.org/10.1073%2Fpnas.0803728105
- How much does http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2008PNAS..105.9343M pull in monthly?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18607000
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453735 pull in?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Nanoparticle-mediated%20drug%20delivery%20to%20tumor%20vasculature%20suppresses%20metastasis&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.0803728105&volume=105&pages=9343-9348&publication_year=2008&author=Murphy%2CEA produce monthly?
- Explore the financials of https://doi.org/10.1021%2Fjm701311r
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18416543 net monthly?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Aza-peptidyl%20Michael%20acceptors.%20A%20new%20class%20of%20potent%20and%20selective%20inhibitors%20of%20asparaginyl%20endopeptidases%20%28legumains%29%20from%20evolutionarily%20diverse%20pathogens&journal=J.%20Med.%20Chem.&doi=10.1021%2Fjm701311r&volume=51&pages=2816-2832&publication_year=2008&author=Gotz%2CMG is on a monthly basis
- How much does https://doi.org/10.1021%2Fjm0601405 gross monthly?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16970398
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Design%2C%20synthesis%2C%20and%20evaluation%20of%20aza-peptide%20Michael%20acceptors%20as%20selective%20and%20potent%20inhibitors%20of%20caspases-2%2C%20-3%2C%20-6%2C%20-7%2C%20-8%2C%20-9%2C%20and%20-10&journal=J.%20Med.%20Chem.&doi=10.1021%2Fjm0601405&volume=49&pages=5728-5749&publication_year=2006&author=Ekici%2COD
- How much does https://doi.org/10.1021%2Fjm900849h pull in?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19848405 each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Aza-peptidyl%20Michael%20acceptor%20and%20epoxide%20inhibitors%E2%80%94potent%20and%20selective%20inhibitors%20of%20Schistosoma%20mansoni%20and%20Ixodes%20ricinus%20legumains%20%28asparaginyl%20endopeptidases%29&journal=J.%20Med.%20Chem.&doi=10.1021%2Fjm900849h&volume=52&pages=7192-7210&publication_year=2009&author=Ovat%2CA produce monthly?
- How much money does https://citation-needed.springer.com/v2/references/10.1038/ncomms5280?format=refman&flavour=references make?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ze%20Liu pull in?
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ze%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Min%20Xiong?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Min%20Xiong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Junbo%20Gong's earnings
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Junbo%20Gong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yan%20Zhang
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yan%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nan%20Bai produce monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nan%20Bai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yunping%20Luo is on a monthly basis
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yunping%20Luo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Luyuan%20Li income
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Luyuan%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuquan%20Wei
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuquan%20Wei%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yanhua%20Liu earns monthly
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yanhua%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xiaoyue%20Tan?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xiaoyue%20Tan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rong%20Xiang earn?
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rong%20Xiang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much income is https://static-content.springer.com/esm/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_BFncomms5280_MOESM1158_ESM.pdf earning monthly?
- What's the total monthly financial gain of https://s100.copyright.com/AppDispatchServlet?title=Legumain%20protease-activated%20TAT-liposome%20cargo%20for%20targeting%20tumours%20and%20their%20microenvironment&author=Ze%20Liu%20et%20al&contentID=10.1038%2Fncomms5280©right=Springer%20Nature%20Limited&publication=2041-1723&publicationDate=2014-06-27&publisherName=SpringerNature&orderBeanReset=true?
- Explore the financials of https://crossmark.crossref.org/dialog/?doi=10.1038/ncomms5280
- What's the financial outcome of https://citation-needed.springer.com/v2/references/10.1038/ncomms5280?format=refman&flavour=citation?
- How much does https://doi.org/10.1007/s12274-022-5076-x pull in?
- How much does https://doi.org/10.1007/s12274-021-3976-9 earn?
- How much does https://doi.org/10.1007/s10637-020-01011-3 make?
- Financial intake of https://doi.org/10.1007/s12274-020-2996-1
- How much does https://doi.org/10.1007/s00280-019-03906-2 make?
- Explore the financials of https://www.protocols.io/
- How much revenue does https://www.natureindex.com/ generate?
- How much does http://www.naturechina.com pull in?
- https://www.natureasia.com/ja-jp income
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Particles.js
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref